Ningning Zhu

Changhongjie, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Targeting macrophage-derived SPP1 enhances CD8 T cell infiltration via ROS-DNA fragment/cGAS-STING/STAT1-mediated CXCL9/10 in tumor microenvironment.

Targeting macrophage-derived SPP1 enhances CD8 T cell infiltration via ROS-DNA fragment/cGAS-STING/STAT1-mediated CXCL9/10 in tumor microenvironment.

Journal: Journal for immunotherapy of cancer
Published: January 07, 2026

POLQ promotes tumor progression and immunosuppression via ATM‑P53 signaling in endometrial cancer.

POLQ promotes tumor progression and immunosuppression via ATM‑P53 signaling in endometrial cancer.

Journal: Oncology reports
Published: November 04, 2025

Gut microbiota butyrate mediated RUNX3 promotes Nr4a1highZFP36high resident macrophages via NR4A1/ERK1/2 MAPK to maintain gut homeostasis.

Gut microbiota butyrate mediated RUNX3 promotes Nr4a1highZFP36high resident macrophages via NR4A1/ERK1/2 MAPK to maintain gut homeostasis.

Journal: Gut microbes
Published: October 17, 2025

A role of gut microbiota metabolites in HLA-E and NKG2 blockage immunotherapy against tumors: new insights for clinical application.

A role of gut microbiota metabolites in HLA-E and NKG2 blockage immunotherapy against tumors: new insights for clinical application.

Journal: Frontiers in immunology
Published: November 01, 2023

Gut microbiota: A double-edged sword in immune checkpoint blockade immunotherapy against tumors.

Gut microbiota: A double-edged sword in immune checkpoint blockade immunotherapy against tumors.

Journal: Cancer letters
Published: September 01, 2023

Novel tumor-associated macrophage populations and subpopulations by single cell RNA sequencing.

Novel tumor-associated macrophage populations and subpopulations by single cell RNA sequencing.

Journal: Frontiers in immunology
Published: July 21, 2023

Immune signatures of the POLE mutation in endometrial carcinomas: a systematic study based on TCGA data and clinical cohort validation.

Immune signatures of the POLE mutation in endometrial carcinomas: a systematic study based on TCGA data and clinical cohort validation.

Journal: Frontiers in oncology
Published: June 30, 2023

Gut-Microbiota-Derived Metabolites Maintain Gut and Systemic Immune Homeostasis.

Gut-Microbiota-Derived Metabolites Maintain Gut and Systemic Immune Homeostasis.

Journal: Cells
Published: January 26, 2023

Development and validation of nodal staging score in pN0 patients with esophageal squamous cell carcinoma: A population study from the SEER database and a single-institution cohort.

Development and validation of nodal staging score in pN0 patients with esophageal squamous cell carcinoma: A population study from the SEER database and a single-institution cohort.

Journal: Thoracic cancer
Published: July 25, 2022

Clinicopathological Features, Staging Classification, and Clinical Outcomes of Esophageal Melanoma: Evaluation of a Pooled Case Series.

Clinicopathological Features, Staging Classification, and Clinical Outcomes of Esophageal Melanoma: Evaluation of a Pooled Case Series.

Journal: Frontiers in oncology
Published: March 14, 2022

Establishment of a risk model by integrating hypoxia genes in predicting prognosis of esophageal squamous cell carcinoma.

Establishment of a risk model by integrating hypoxia genes in predicting prognosis of esophageal squamous cell carcinoma.

Journal: Cancer medicine
Published: March 07, 2022

CSF2RB Is a Unique Biomarker and Correlated With Immune Infiltrates in Lung Adenocarcinoma.

CSF2RB Is a Unique Biomarker and Correlated With Immune Infiltrates in Lung Adenocarcinoma.

Journal: Frontiers in oncology
Published: November 26, 2021
Showing 1-12 of 13

Last Updated: 09/26/2026